ebook Munafa Stock Market Course + Intraday & FNO calls  

       

LLY announcements Eli Lilly And Company announcements and dividends declared NYSE

Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY

Eli Lilly And Company LLY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Eli Lilly And Company LLY

Eli Lilly plans to launch experimental weight-loss pill in India, says executive
Lilly's orforglipron is designed to mimic the appetite-suppressing GLP-1 hormone targeted by the company's blockbuster injection tirzepatide, sold under the brand names Mounjaro and Zepbound.
Announcement as on 25 September 2025

Eli Lilly To Build .5 Bln Manufacturing Plant In Texas For Obesity Pill Production
(RTTNews) - Eli Lilly And Co. (LLY) announced on Tuesday that it will spend .5 billion to construct a manufacturing plant in Houston, Texas, with the goal of increasing production of its pipeline of small molecule medications, which includes the much-dis
Announcement as on 23 September 2025

After Mounjaro Jab, Eli Lilly plans weight loss pill launch in India
Eli Lilly plans to launch an oral weight loss drug, orforglipron, after Mounjaro's India success. Regulatory submissions are expected soon, with potential approvals by 2026. This pill targets a broader patient group than injectables. Studies show orforglip
Announcement as on 18 September 2025

Why Eli Lilly Stock Was a Winner Today
Key PointsThere's a chance that an investigational obesity drug late in its development stage could be fast-tracked for FDA approval.
Announcement as on 16 September 2025

Eli Lilly launches Mounjaro KwikPen for diabetes, obesity treatment in India
Eli Lilly has launched Mounjaro in KwikPen, a prefilled pen for weekly administration, in India to treat type 2 diabetes and obesity. Priced from Rs 14,000, it offers personalized treatment with six dose strengths. Mounjaro, a dual GIP and GLP-1 receptor a
Announcement as on 13 August 2025

Announcements by Eli Lilly And Company first page | Next page | Prev page |

LLY Eli Lilly And Company current price & indicator signals

Moving Averages for Eli Lilly And Company

  • 5Day Average: 1002.07
  • 12Day Average: 1029.32
  • 20Day Average: 1037.91
  • 50Day Average: 931.3
  • 100Day Average: 832.4
  • 150Day Average: 810.32
  • 200Day Average: 813.32

LLY Indicators & signals

Indicator MACD (12,26,9)

1018.37, 998.77, 32.67
Indicator MACD is in positive zone

Indicator ADX (14)

0.07, 22.66, 22.63
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 58
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
12 Fri Dec 2025 1027.51 1003.50 to 1028.90 1.8% 1.12 times
11 Thu Dec 2025 1009.38 987.00 to 1031.56 1.58% 1.55 times
10 Wed Dec 2025 993.64 977.12 to 1003.00 1.16% 1.02 times
09 Tue Dec 2025 982.22 979.18 to 1012.00 -1.54% 0.88 times
08 Mon Dec 2025 997.59 988.88 to 1014.20 -1.21% 1.05 times
05 Fri Dec 2025 1009.77 1004.00 to 1027.39 -0.47% 0.44 times
04 Thu Dec 2025 1014.49 1007.18 to 1032.63 -1.85% 1.32 times
03 Wed Dec 2025 1033.56 1022.32 to 1051.48 -1.13% 1.18 times
02 Tue Dec 2025 1045.37 1040.36 to 1068.18 -1.18% 0.58 times
01 Mon Dec 2025 1057.89 1055.00 to 1084.15 -1.63% 1.05 times
28 Fri Nov 2025 1075.47 1067.69 to 1099.05 -2.67% 0.94 times
26 Wed Nov 2025 1104.92 1098.10 to 1119.15 -0.42% 0.47 times

Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

LLY announcements Eli Lilly And Company announcements and dividends declared NYSE

 

Back to top